Board of Directors

Cognition Therapeutics Appoints Brett P. Monia to its Board of Directors

Pittsburgh, October 27, 2020 — Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular damage response pathways, today announced the appointment of Brett P. Monia, Ph.D. to its board of directors. Dr. Monia is a founding member and the current CEO of Ionis Pharmaceuticals, a pioneer in …

Cognition Therapeutics Appoints Brett P. Monia to its Board of Directors Read More »

Cognition Therapeutics Elects Lisa Ricciardi to its Board of Directors

Pittsburgh, March 26, 2019 — Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative diseases and disorders caused by membrane trafficking dysfunction, today announced the appointment of Lisa Ricciardi to its Board of Directors. Ms. Ricciardi is a life sciences executive with broad industry experience, …

Cognition Therapeutics Elects Lisa Ricciardi to its Board of Directors Read More »

Scroll to Top